@article{5a77d839cd2243d697e5d03647e80a67,
title = "COVID-19 in the pregnant or postpartum MS patient: Symptoms and outcomes",
abstract = "Women with multiple sclerosis (MS) are often of childbearing age. Thirty-six women with MS who were pregnant (n = 27) or within 6 weeks postpartum (n = 9) were reported in the North American COViMS registry and their COVID-19 outcomes were described. One pregnant and one postpartum woman were hospitalized. No deaths occurred. To compare COVID-19 clinical outcomes in pregnant and postpartum females with females who were not pregnant or postpartum, a 1:2 propensity score match was performed. While not powered to detect small differences, it was reassuring that no increased risks for those with MS who were pregnant/postpartum were revealed.",
keywords = "COVID-19, Multiple sclerosis, Postpartum, Pregnancy, SARS-CoV-2",
author = "Amber Salter and Cross, {Anne H.} and Cutter, {Gary R.} and Fox, {Robert J.} and Li, {David K.B.} and Bruce Bebo and June Halper and Pamela Kanellis and Kottil Rammohan and Newsome, {Scott D.}",
note = "Funding Information: Dr Salter reports honoraria for consulting for Gryphon Bio, LLC and research funding from Multiple Sclerosis Society of Canada, National Multiple Sclerosis Society, CMSC and the US Department of Defense. She is a member of the Editorial Board for Neurology. Dr. Salter is a member of the Data and Safety Monitoring Board for Premature Infants Receiving Milking or Delayed Cord Clamping (PREMOD2), Central Vein Sign: A Diagnostic Biomarker in Multiple Sclerosis (CAVS-MS), and Ocrelizumab for Preventing Clinical Multiple Sclerosis in Individuals With Radiologically Isolated Disease (CELLO). Funding Information: Dr Rammohan reports honoraria from Alexion, Sanofi Genzyme, Genentech, Novartis, EMD Serono, Biogen, Horizon and grants from Alexion, Sanofi Genzyme, Genentech, Novartis, Biogen. Publisher Copyright: {\textcopyright} 2022 Elsevier B.V.",
year = "2022",
month = sep,
doi = "10.1016/j.msard.2022.104028",
language = "English",
volume = "65",
journal = "Multiple Sclerosis and Related Disorders",
issn = "2211-0348",
}